In the April 2023 issue of Human Gene Therapy (vol. 34, no. 7-8; 339–340), the article entitled “Letter to the Editor: A Favorable Benefit–Risk Balance Maybe Expected with Replication-Defective Adenovirus-Mediated Interferon Gene Therapy for Cancer Treatment” by Qin requires correction.
This article was originally published under the copyright of Mary Ann Liebert, Inc. publishers. It has now been updated to reflect Open Access, with copyright transferring to the author(s), and a Creative Commons License (CC-BY) added (http://creativecommons.org/licenses/by/4.0). The CC-BY license goes into effect April 28, 2023.
The online version of this article has been corrected to reflect this.
